MBX Biosciences Statistics

Total Valuation

MBX Biosciences has a market cap or net worth of $363.58 million. The enterprise value is $86.73 million.

Market Cap	363.58M
Enterprise Value	86.73M

Important Dates

The next estimated earnings date is Friday, March 7, 2025, before market open.

Earnings Date	Mar 7, 2025
Ex-Dividend Date	n/a

Share Statistics

MBX Biosciences has 33.42 million shares outstanding. The number of shares has increased by 71.70% in one year.

Current Share Class	33.42M
Shares Outstanding	33.42M
Shares Change (YoY)	+71.70%
Shares Change (QoQ)	-56.87%
Owned by Insiders (%)	3.14%
Owned by Institutions (%)	39.87%
Float	13.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.34
P/TBV Ratio	1.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 25.75, with a Debt / Equity ratio of 0.00.

Current Ratio	25.75
Quick Ratio	25.45
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-21.94%
Revenue Per Employee	n/a
Profits Per Employee	-$2.04M
Employee Count	27
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	14.52
200-Day Moving Average	n/a
Relative Strength Index (RSI)	45.52
Average Volume (20 Days)	319,195

Short Selling Information

The latest short interest is 2.80 million, so 8.38% of the outstanding shares have been sold short.

Short Interest	2.80M
Short Previous Month	2.03M
Short % of Shares Out	8.38%
Short % of Float	20.57%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-59.58M
Pretax Income	-47.20M
Net Income	-55.18M
EBITDA	-59.35M
EBIT	-59.58M
Earnings Per Share (EPS)	-$4.01

Full Income Statement

Balance Sheet

The company has $277.06 million in cash and $210,000 in debt, giving a net cash position of $276.85 million or $8.28 per share.

Cash & Cash Equivalents	277.06M
Total Debt	210,000
Net Cash	276.85M
Net Cash Per Share	$8.28
Equity (Book Value)	271.37M
Book Value Per Share	8.13
Working Capital	270.25M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$49.79 million and capital expenditures -$837,000, giving a free cash flow of -$50.63 million.

Operating Cash Flow	-49.79M
Capital Expenditures	-837,000
Free Cash Flow	-50.63M
FCF Per Share	-$1.51

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MBX Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-71.70%
Shareholder Yield	-71.70%
Earnings Yield	-15.18%
FCF Yield	-13.92%

Analyst Forecast

The average price target for MBX Biosciences is $37.25, which is 242.37% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$37.25
Price Target Difference	242.37%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2